CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Public ClinicalTrials.gov record NCT01268319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The CANARY (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow) Study is a pivotal trial to evaluate criteria for defining a Lipid Core Plaque (LCP) that is at high risk of rupturing during standard of care therapy and causing intra-procedural complications. If plaques that require treatment are at higher than normal risk of causing intra-procedural complications, some life threatening, the treating physician is better informed and may opt to take precautionary measures to mitigate the risk or result of a complication. The CANARY Study is also designed to evaluate the feasibility of using a distal embolization protection device (EPD) as a means to prevent heart attacks triggered by the embolization of plaque during standard care therapy. It is thought that the EPD will prevent plaque from going downstream during treatment and obstructing other heart vessels. These obstructions could cause heart attacks by preventing blood from reaching heart muscle tissue.
Study identification
- NCT ID
- NCT01268319
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 85 participants
Conditions and interventions
Interventions
- Embolic Protection Device (EPD) Device
- Intracoronary Spectroscopy and Ultrasonic Evaluation Device
- Angioplasty and Stent Implant Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Aug 31, 2014
- Completion
- Oct 31, 2016
- Last update posted
- Jun 11, 2017
2011 – 2016
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Healthcare Shea | Scottsdale | Arizona | 85258 | — |
| San Francisco Veterans Affairs Medical Center | San Francisco | California | 94121 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Spectrum Health System | Grand Rapids | Michigan | 49503 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| Mount Sinai School of Medicine Hospital | New York | New York | 10029 | — |
| Pinnacle Health Cardiovascular Insititute | Harrisburg | Pennsylvania | 17101 | — |
| Medical University of South Carolina Hospital | Charleston | South Carolina | 29403 | — |
| Veterans Affairs North Texas Health Care Systems | Dallas | Texas | 75216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01268319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01268319 live on ClinicalTrials.gov.